-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
CymaBay Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2012 to 2023.
- CymaBay Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2023 was 106M shares, a 21% increase year-over-year.
- CymaBay Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 106M shares, a 21% increase from 2022.
- CymaBay Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 87.8M shares, a 23.6% increase from 2021.
- CymaBay Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 71.1M shares, a 3.14% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)